Tradestie Institutional Equity Comparison Engine · Market Close Apr 06, 2026

BFLY.WS vs HOLX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HOLX Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

HOLX Overall Winner 6-Pillar Tally: BFLY.WS 0 – 6 HOLX Matrix Metrics: BFLY.WS 0 – 10 HOLX

As of Apr 06, 2026, Hologic Inc (HOLX) is the stronger overall head-to-head candidate over Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of (BFLY.WS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BFLY.WS carries a Unified Composite Score of 33.5/100 (SELL) at $0.01 (N/M Forward P/E, N/A operating margin), whereas HOLX carries 64.2/100 (BUY) at $76.01 (20.1x Forward P/E, 23.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BFLY.WS vs HOLX
BFLY.WS NYSE
Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$0.01
-50.0% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.95β · 347% Vol
Unified Composite Score
33.5 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
HOLX NASDAQ Head-to-Head Winner
Hologic Inc
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$76.01
+0.48% 1D
Market Cap $16.9B
TTM Revenue $4.13B
Forward P/E 20.1x
Beta / 30D Vol 0.08β · 3% Vol
Unified Composite Score
64.2 / 100 BUY
Tech 75.0 Fund 61.0 Flow 54.0 Mom 49.2
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 69
RSI-14: 69.0 · SMA20: $75.47 · SMA50: $75.29

6-Pillar Scorecard Institutional Category Breakdown (BFLY.WS 0 – 6 HOLX)

Columns: Metric · BFLY.WS · HOLX
1. Valuation Multiples HOLX
Forward P/E N/M 20.1x
Trailing P/E N/M 31.4x
PEG Ratio N/M 1.66x
EV / Revenue N/M 4.1x
2. Growth & Scale HOLX
Revenue Growth (YoY) N/A +2.5%
Earnings Growth (YoY) N/A -9.2%
TTM Revenue (USD) N/A $4.13B
Market Cap N/A $16.9B
3. Profitability & Quality HOLX
Gross Margin N/A 60.4%
Operating Margin N/A 23.0%
Net Profit Margin N/A 13.2%
Return on Equity (ROE) N/A 10.9%
4. Balance Sheet & Cash Flow HOLX
Cash Generation (TTM) N/A $1.35B EBITDA
Cash Flow Margin N/A 32.7% EBITDA Mgn
Net Cash / Leverage N/A ROE $23.51 Book/Sh · 10.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HOLX
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 6.3% (3rd %ile)
Put/Call OI Skew N/A 6.20x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat HOLX
OpEx & R&D Intensity N/A 37.4% of Rev ($1.54B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role X-Ray Apparatus & Tubes & Related Irradiation Apparatus Operator Medical Instruments & Supplies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BFLY.WS (0) vs HOLX (10)
Institutional Metric BFLY.WS HOLX Criterion Row Edge
Market Capitalization
Scale
N/A $16.9B Larger Scale HOLX
Trailing P/E Ratio
Valuation
N/M 31.4x Lower Multiple HOLX
Forward P/E Ratio
Valuation
N/M 20.1x Lower Multiple HOLX
Revenue Growth (YoY)
Growth
N/A +2.5% Higher Growth HOLX
Operating Margin (TTM)
Profitability
N/A 23.0% Higher Margin HOLX
Net Profit Margin
Profitability
N/A 13.2% Higher Margin HOLX
Return on Equity (ROE)
Capital Efficiency
N/A 10.9% Higher ROE HOLX
52-Week Range Position
Momentum
0% ($0–$0) 100% ($52–$76) Stronger Trend HOLX
Beta / 30D Volatility
Risk Regime
1.95β · 347% Vol 0.08β · 3% Vol Lower Realized Risk HOLX
Unified Institutional Score
Composite Signal
33.5 / 100 (SELL) 64.2 / 100 (BUY) Higher Composite HOLX
Trailing 12M Revenue (USD)
Operating Scale
N/A $4.13B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 60.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 1.66x PEG · 4.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $1.35B EBITDA ($23.51 Book/Sh · 10.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HOLX +69.94 pp
BFLY.WS: -69.89% · HOLX: +0.05%
3M Horizon HOLX +77.97 pp
BFLY.WS: -76.96% · HOLX: +1.01%
6M Horizon HOLX +77.97 pp
BFLY.WS: -76.96% · HOLX: +1.01%
1Y Horizon HOLX +77.97 pp
BFLY.WS: -76.96% · HOLX: +1.01%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BFLY.WS vs HOLX. Trailing 12-month operating profitability (BFLY.WS N/A vs HOLX 23.0%) and valuation multiples (BFLY.WS N/M vs HOLX 20.1x Forward P/E) are benchmarked directly in Pillar 4 below.

BFLY.WS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
HOLX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.13B
Gross Margin60.4%
Op. Margin23.0%
ROE / Fwd P/E10.9% · 20.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BFLY.WS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BFLY.WS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HOLX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 6.3%
IV Percentile 3rd %ile
Put/Call OI Skew 6.20x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact HOLX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BFLY.WS Moat Profile Cyclical / Execution-Driven Positioning
X-Ray Apparatus & Tubes & Related Irradiation Apparatus Operator
Competes within the X-Ray Apparatus & Tubes & Related Irradiation Apparatus value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HOLX Moat Profile Scale & Operating Efficiency Moat
Medical Instruments & Supplies Operator
Competes within the Medical Instruments & Supplies value chain with $16.9B market capitalization and 23.0% operating margin.
OpEx & R&D Reinvestment 37.4% of Rev ($1.54B)
90D Engineering Disclosures 0 Published

Investor FAQ BFLY.WS vs HOLX Key Questions & Quantitative Answers

As of Apr 06, 2026, Hologic Inc (HOLX) is the stronger overall head-to-head candidate over Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of (BFLY.WS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BFLY.WS carries a Unified Composite Score of 33.5/100 (SELL) at $0.01 (N/M Forward P/E, N/A operating margin), whereas HOLX carries 64.2/100 (BUY) at $76.01 (20.1x Forward P/E, 23.0% operating margin). Technically, BFLY.WS sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and HOLX sits in a Neutral phase (RSI 69.0, UNCLASSIFIED options structure).

HOLX leads the Growth & Scale pillar: BFLY.WS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HOLX at +2.5% YoY revenue growth and -9.2% YoY earnings growth on $4.13B TTM revenue (60.4% gross margin, 23.0% operating margin). On trailing 12-month operating scale, BFLY.WS generates N/A in USD-normalized revenue versus $4.13B for HOLX. In operating R&D and SG&A reinvestment, BFLY.WS deploys N/A (0 90-day corporate R&D disclosures) versus 37.4% of Rev ($1.54B) (0 disclosures) for HOLX.

HOLX screens cheaper on headline valuation multiples. BFLY.WS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HOLX trades at 20.1x Forward P/E, 31.4x Trailing P/E, 1.66x PEG, and 4.1x EV/Revenue (32.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BFLY.WS (N/A ROE) versus HOLX (10.9% ROE) capital efficiency.

In options market volatility and institutional positioning, BFLY.WS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.95β · 347% Vol realized risk). By comparison, HOLX carries 6.3% implied volatility (3rd %ile, Compressed (<25th %ile)), a 6.20x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.08β · 3% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (BFLY.WS) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Apr 06, 2026. For educational research only; not investment advice.